Results 261 to 270 of about 27,386 (300)

Organoids as an emerging platform for osteoarthritis drug development

open access: yes
Clinical and Translational Medicine, Volume 16, Issue 9, September 2026.
Xukun Lyu, Jianhua Wang, Jiacan Su
wiley   +1 more source

Bioprinted vascularized soft-tissue flaps with an integrated arterial-venous loop.

open access: yesCell Biomater
Fischer EO   +12 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

In situ bioprinting – Bioprinting from benchside to bedside?

Acta Biomaterialia, 2020
Bioprinting technologies have been advancing at the convergence of automation, digitalization, and new tissue engineering (TE) approaches. In situ bioprinting may be favored during certain situations when compared with the conventional in vitro bioprinting when de novo tissues are to be printed directly on the intended anatomical location in the living
Deepak Choudhury   +2 more
exaly   +3 more sources

Bioprinting

2021
Abstract Abstract: This book describes how bioprinting emerged from 3D printing and details the accomplishments and challenges in bioprinting tissues of cartilage, skin, bone, muscle, neuromuscular junctions, liver, heart, lung, and kidney.
Henk ten Have   +1 more
  +4 more sources

Bioprinting

2014
The main goal of tissue or organ engineering is to reconstruct a damaged or diseased tissue or organ with cells, biomaterials and bioactive molecules. Recently, many tissue engineering approaches are based on developing highly porous tissue scaffolds and seeding cells into the scaffold with or without biologically active molecules to reinstate damaged ...
Chee Kai Chua, Wai Yee Yeong
  +4 more sources

Home - About - Disclaimer - Privacy